Jyothi Datta is a journalist at businessline. She covers a diverse range of topics, focusing on medicine and healthcare, pharmaceuticals, and business economics, with a particular interest in public health, consumer health, and patient care. Jyothi's insights and expertise have been featured in various publications, including businessline.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
India (National)
Not enough data
Jyothi Datta's coverage primarily focuses on healthcare and pharmaceuticals, with a strong emphasis on COVID-19, medical research, vaccines, public health, and healthcare. She frequently covers government announcements and press releases in her articles.
Given the nature of Jyothi's coverage, she would likely be interested in pitches that offer expert insights into the latest developments in healthcare policies or breakthroughs in medical research. Furthermore, sources who can provide data-driven analysis related to public health trends or vaccine efficacy may find success when reaching out to Jyothi.
Although no specific geographic focus is indicated for Jyothi's coverage attributes suggests that she takes an international view of healthcare topics. Therefore, experts from around the world could potentially engage effectively with her through relevant and insightful pitches.
This information evolves through artificial intelligence and human feedback. Improve this profile .
E-pharmacies face scrutiny over regulatory gaps, deep discounts, and online prescriptions, raising concerns for local chemists and patient safety.
By: Jyothi Datta
Zaynich (cefepime and zidebactam) is an injectable antibiotic comprising cefepime, a cephalosporin antibacterial drug and zidebactam, a non-β-lactam antibacterial and β-lactamase inhibitor
By: Jyothi Datta
Some concrete measures being discussed include having standard treatment protocols for common ailments to start with, which could help define pricing, says Dr S Prakash, Chief Executive Officer at General Insurance Council
Calls on corporates to recognise this workplace reality and extend support services
By: Jyothi Datta
Cisplatin and carboplatin are the “back-bone of chemotherapy”, said Aggarwal
Tata Memorial representative suggests linking drug-price revisions to API costs to prevent supply shortages
Discover Habuild, a unique yoga initiative helping the 50-plus community build healthy habits through simple practices and inclusive support.
By: Jyothi Datta
Amends Drugs Rules to curb misuse; distribution restricted to ‘duly licensed pharmacies'
AstraZeneca's MD hints at India's potential inclusion in global trials for its promising oral GLP-1 weight loss and diabetes drug.
A Policybazaar study highlights the need for transparency and proactive communication in the health insurance claim process.
